Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Change in Accured Expenses (2019 - 2025)

Historic Change in Accured Expenses for Strata Critical Medical (SRTA) over the last 7 years, with Q3 2025 value amounting to $7.5 million.

  • Strata Critical Medical's Change in Accured Expenses rose 102244.14% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 million, marking a year-over-year increase of 34882.89%. This contributed to the annual value of -$8.3 million for FY2024, which is 19214.28% down from last year.
  • Latest data reveals that Strata Critical Medical reported Change in Accured Expenses of $7.5 million as of Q3 2025, which was up 102244.14% from $3.2 million recorded in Q2 2025.
  • In the past 5 years, Strata Critical Medical's Change in Accured Expenses ranged from a high of $7.5 million in Q3 2025 and a low of -$10.2 million during Q1 2024
  • In the last 5 years, Strata Critical Medical's Change in Accured Expenses had a median value of $2.2 million in 2021 and averaged $1.4 million.
  • As far as peak fluctuations go, Strata Critical Medical's Change in Accured Expenses skyrocketed by 669235.84% in 2021, and later tumbled by 22833.84% in 2023.
  • Quarter analysis of 5 years shows Strata Critical Medical's Change in Accured Expenses stood at $1.9 million in 2021, then surged by 193.4% to $5.6 million in 2022, then fell by 12.08% to $5.0 million in 2023, then tumbled by 100.04% to -$2000.0 in 2024, then skyrocketed by 374150.0% to $7.5 million in 2025.
  • Its last three reported values are $7.5 million in Q3 2025, $3.2 million for Q2 2025, and -$2.3 million during Q1 2025.